CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions		3 Months Ended		9 Months Ended
		Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Net Sales		$ 20,068	$ 19,381	$ 61,453	$ 60,672
Cost of Products Sold		10,404	10,326	32,147	31,355
Selling, General and Administrative Expense		5,416	5,031	15,334	15,102
Operating Income		4,248	4,024	13,972	14,215
Interest Expense		(222)	(109)	(516)	(324)
Interest Income		83	9	191	30
Other Non-operating Income/(Loss), Net		179	147	473	424
Earnings/(Loss) from Continuing Operations Before Income Taxes		4,288	4,071	14,120	14,345
Income Taxes on Continuing Operations		864	704	2,774	2,610
Net Earnings		3,424	3,367	11,346	11,735
Net Income (Loss) Attributable to Noncontrolling Interest		27	12	77	45
Net Income (Loss) Attributable to Parent		$ 3,397	$ 3,355	$ 11,269	$ 11,690
Basic Net Earnings Per Common Share
Basic Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.41	$ 1.37	$ 4.67	$ 4.76
Diluted Net Earnings Per Common Share
Diluted Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.37	$ 1.33	$ 4.53	$ 4.59
Diluted Weighted Average Common Shares Outstanding		2,473.2	2,530.2	2,486.0	2,544.4

[1] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

[2] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.